发明名称 Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof
摘要 The present invention provides for a method for treating a disease condition associated with PI3-kinase α and/or mTOR in a subject. In another aspect, the invention provides for a method for treating a disease condition associated with PI3-kinase α and/or mTOR in a subject. In yet another aspect, a method of inhibiting phosphorylation of both Akt (S473) and Akt (T308) in a cell is set forth.
申请公布号 US9295673(B2) 申请公布日期 2016.03.29
申请号 US201213403856 申请日期 2012.02.23
申请人 Intellikine LLC 发明人 Ren Pingda;Liu Yi;Jessen Katayoun;Guo Xin;Rommel Christian;Wilson Troy Edward
分类号 A61K31/551;A61K31/4439;A61K31/4745;A61K31/498;A61K45/06;A61K31/501;A61K31/517;A61K31/519;A61K31/527;A61K31/53;A61K31/5377;A61K31/541 主分类号 A61K31/551
代理机构 Honigman Miller Schwartz and Cohn LLP 代理人 Honigman Miller Schwartz and Cohn LLP ;Yang Lucy X.;O'Brien Jonathan P.
主权项 1. A method for treating breast cancer comprising administering to a subject in need thereof a therapeutically effective amount of the mTOR inhibitor: or a pharmaceutically acceptable salt thereof; and a therapeutically effective amount of the PI3-kinase α inhibitor: or a pharmaceutically acceptable salt thereof.
地址 La Jolla CA US